Skip to main content
. 2021 Oct 28;12:778359. doi: 10.3389/fimmu.2021.778359

Figure 4.

Figure 4

Blockade of IL-6/IL-6R signaling reduces B cells. B cells (CD19+) were detected by flow cytometry 4 d after cardiac transplantation in the control, tocilizumab, and IL-6-/- groups. Representative dot plots for frequencies and quantitative analysis of frequencies and counts of B cells in circulation (A–C), spleens (D–F), and cardiac allografts (G–I) (n = 4/group). *P<0.05; **P<0.01; ***P<0.001; NS, no significance.